← All Rf Acquisition CORP Ii filings

Rf Acquisition CORP Ii 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
RFAI
Rf Acquisition CORP Ii
10-K: RF Acquisition Corp II Details Nanyang Biologics Merger, Faces Going Concern Doubt
RF Acquisition Corp II filed its annual 10-K report, disclosing a definitive business combination agreement with Nanyang Biologics Pte. Ltd. and an extension of its deadline to August 15, 2026, following significant share redemptions.
NASDAQ
RFAI
Rf Acquisition CORP Ii
10-K: RF Acquisition Corp II Outlines Share Structure and Redemption Rights in 10-K Filing
RF Acquisition Corp II's 10-K filing details the company's share structure, redemption rights, and plans to identify a business combination target in the deep technology sector.